Accessory PathwayNCT03875222
New Criteria for Accessory Pathway Localization From Surface ECG
An observational study of Accessory Pathway, run by Assiut University.
Trial summary
study for discovering new criteria for localization of site of accessory pathway from surface ECG Read more about this study
- Who is it for?
- Ages 10 to 90 years
- Conditions the study is for
- Accessory Pathway
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- Apr 2019to Aug 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 90 years
- All sexes
- Child, Adult, Older adult
Study population: any patient with manifest accessory pathway between 10 and 90 years of age undergoing EP maping and ablation.
Who may be able to join
- any patient with manifest accessory pathway .
Who cannot join
- multiple accessory pathways .previous ablation.
About this study
Official title: Studying New Criteria for Prediction of Site of Accessory Pathway From Surface ECG
study for discovering new criteria for localization of site of accessory pathway from surface ECG
Read the detailed description
the study aims for discovering new criteria for percise localization of accessory pathway from surface ECG in referance to final flouroscopic ablation site
- Conditions
- Accessory Pathway
- Medical subject headings
- Pre-Excitation Syndromes
What is being measured
The primary outcome is the main question the study is designed to answer.
percise localization of accessory pathway from surface ECG in referance to successful ablation site
successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2019
- Study startApr 2019 (estimated)
- Primary completionApr 2021 (estimated)
- Study completionAug 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Accessory PathwayStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Haidy Yacoup Daoud Danial, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03875222
- Sponsor's protocol ID
- Accessory pathway location
- Status last verified
- Mar 2019
- First submitted
- 13 Mar 2019
- Last updated
- 19 Mar 2019
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Mar 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Studying New Criteria for Prediction of Site of Accessory Pathway From Surface ECG
- ClinicalTrials.gov ID
- NCT03875222
- Acronym / sponsor ID
- Accessory pathway location
- Conditions
- Accessory Pathway
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- Apr 2019 (estimated)
- Primary completion
- Apr 2021 (estimated)
- Study completion
- Aug 2021 (estimated)
- First posted
- 14 Mar 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
study for discovering new criteria for localization of site of accessory pathway from surface ECG
Detailed description
the study aims for discovering new criteria for percise localization of accessory pathway from surface ECG in referance to final flouroscopic ablation site
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 10 to 90 years
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- any patient with manifest accessory pathway between 10 and 90 years of age undergoing EP maping and ablation.
Key inclusion criteria (1 listed)
- any patient with manifest accessory pathway .
Key exclusion criteria (1 listed)
- multiple accessory pathways .previous ablation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
percise localization of accessory pathway from surface ECG in referance to successful ablation site
Time frame: 2 years
successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Mar 2019.
Related trials for Accessory Pathway
Not yet recruiting
Stroke Cerebral Reorganization Pathways (SPECTRE)
Brain Diseases, Ischemic Stroke
Not yet recruitingObservational study
Comparative Outcomes of Radiofrequency Ablation of Concealed and Manifest Accessory Pathways: a Single Center, Retrospective Observational Study
Atrioventricular Reentrant Tachycardias, Wolff-Parkinson-White (WPW) Syndrome
Not yet recruitingObservational study
AI-ECG Accessory Pathway Localisation Study
Accessory Pathway, Artifical Intelligence
Active, not recruitingObservational study
Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)
Cardiac Death, Cardiac Death, Sudden
RecruitingObservational study
Discrimination of Right Versus Left Septal Accessory Pathway Before and During the Electrophysiological Study
WPW Syndrome, Accessory Pathway
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Accessory Pathway, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
percise localization of accessory pathway from surface ECG in referance to successful ablation site (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2019.